A
A
A
Patient / Consumer
Know more about Medicines Regulation Know more about access to medicines which do not have a Marketing Authorisation Report a Side Effect Biological and Biosimilar Medicinal Products How we monitor the safety of medicines Know more about the Medicines Supply Chain Know more about Use of Medicines Information Leaflets on Medicines Search for your Medicines
Industry
Pharmaceutical Activities and Inspections Product Quality Defects Reporting Scientific Advice Advertising Registering a product Pharmacovigilance Fees
Health Care Professionals
Search Authorised Medicines in Malta Adverse Drug Reaction Reporting How we monitor the safety of medicinal products Safety Information Clinical Trials Named patient basis application Product Quality Defects Reporting Medicines supply chain and regulation Advertising
Home / News Archive / News Details

COVID-19 Vaccine AstraZeneca: Update on ongoing evaluation of blo...

Published: 25 Mar 2021

 

The Malta Medicines Authority intervention on the EU medicine shortages scenario

 

The Malta Medicines Authority is closely monitoring the European and local market for shortages of medicines. More information click here.

 


The European Medicines Agency (EMA) published an update on ongoing evaluation of blood clot cases. 
For more information please follow this link.
Previous News Update
Next News Update

Latest News Updates

07 Jan 2023

Press Release 'The Malta Medicines Authority intervention on the EU medicine shortages scenario'

Find out more

Latest News Updates

07 Jan 2023

Press Release 'The Malta Medicines Authority intervention on the EU medicine shortages scenario'

Find out more

Latest News Updates

07 Jan 2023

Press Release 'The Malta Medicines Authority intervention on the EU medicine shortages scenario'

Find out more